Report Highlights
The global market of photomedicine, including drugs and devices, was valued at $609.7 million in 2013. The market is expected to reach $616.8 million in 2014 and $754 million in 2019, a compound annual growth rate (CAGR) of 4.1% for the five-year period, 2014 to 2019.
Report Includes
- An overview of the global markets for photomedicine, a field of medicine that comprises pathologies caused by light and therapeutic applications of light itself.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
- Information focused on medical equipment (such as lasers, light emitting diodes and other kinds of light technologies) which are employed to treat and diagnose a variety of diseases like skin conditions (psoriasis, vitiligo, cancer etc), seasonal and non-seasonal medical conditions, sleep disorders, and more.
- Coverage of therapeutic areas will include dermatology, surgery, optical diagnostics, cardiology, and oncology.
- Analysis of important market dynamics such as growth drivers, inhibitors, and opportunities.
- Comprehensive company profiles of major players in the photomedicine industry.
SCOPE OF THE REPORT
The global market of photomedicine will grow to about $754 million by 2019 at a compound annual growth rate of 4.1% from 2014 to 2019. This report provides a detailed segmentation by region, by products and type of products, by therapeutic areas and by type of treatment. Profiles of key market players are also included. Major products that generate the largest revenues, as well as the most-valuable R&D products that will come on the market up to 2019 are provided.
In-depth competitive market analysis is discussed, with examples of how new products will enter the market or how existing products will survive or perish. The report also includes descriptions of current and future technologies for drugs and devices used in photomedicine. In the future, nanotechnology will play a pivotal role in drug and discovery innovation.
ANALYST’S CREDENTIALS
Alessandro Varotto has a PhD in Chemistry with a specialty in Nanotechnology and Materials Science. Dr. Varotto has worked as a research scientist in both academic and industry environments. He is the author of about 20 peer-reviewed research articles, patents, a book and dozens of technical papers in the field of life science. His expertise includes chemistry and nanomaterials for the pharmaceutical and medical device industries.
Related Reports
Mid-Infrared Lasers: Technologies, Applications and Global Markets
The global market for mid-infrared (MID-IR) lasers in 2013 was worth $475 million. This market is expected to grow at a compound annual growth rate (CAGR) of 8.2% between 2014 and 2019. This will result in nearly $501.2 million in 2014 and $742.6 million global market in 2019.
Operating Room Equipment: Global Markets
The global operating room market is expected to grow from nearly $13.1 billion in 2014 to reach nearly $21.0 billion in 2019, a compound annual growth rate (CAGR) of 9.8% for the period of 2014 to 2019.
Global Markets and Technologies for Medical Lasers
The global market for medical laser devices was $2.7 billion in 2010. As it recovers from the effects of the recent recession, the market is expected to increase to more than $3 billion in 2011 and $6.8 billion in 2016, a compound annual growth rate (CAGR) of 17.3% over the 5-year period.
Global Markets for Laser Systems, Components and Materials
This report is an attempt to list, elaborate, highlight, and analyze the multitudes of demand and supply side dynamics of lasers at large. Includes forecasts through 2016.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More